Description
IGF::CL,CT::IGF REAGENT TEST
First action · last action
2015-10-01 · 2018-04-20
Transactions
3
First transaction's obligation
$24,178
Base + all options value (sum of deltas)
$27,743
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-10-01+$24,178= $24,178
- Mod P000012016-08-31+$5,181= $29,359
- Mod P000022018-04-20-$1,616= $27,743
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-10-01 | +$24,178 | $24,178 | IGF::CL,CT::IGF REAGENT TEST |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2016-08-31 | +$5,181 | $29,359 | IGF::CL,CT::IGF REAGENT TEST |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2018-04-20 | −$1,616 | $27,743 | IGF::CL,CT::IGF REAGENT TEST |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DNQ4H6RCTMJ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26220N0113 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $74,577 | FY2020 |
| 36C26219N0189 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $48,385 | FY2019 |
| 36C25919N0012 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $80,000 | FY2019 |
| 36C25918N1818 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $20,599 | FY2018 |
| 36C26018P0854 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $47,945 | FY2018 |
| 36C24418P0693 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $80,066 | FY2018 |
Other recipients under Q301 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626F0151 | LIFE SCIENTIFIC, INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $69,085 | FY2026 |
| 36C25626N0694 | QUEST DIAGNOSTICS INCORPORATED | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $75,225 | FY2026 |
| 36C25626N0705 | VERACYTE, INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $49,730 | FY2026 |
| 36C25626N0672 | BAYLOR COLLEGE OF MEDICINE | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $2,035,789 | FY2026 |
| 36C25626D0072 | BAYLOR COLLEGE OF MEDICINE | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25616P0089_3600_-NONE-_-NONE- · retrieved 2026-09-26.